Login
$BCAX
$9.70 -$0.32 (3.19%) Live

$BCAX SEC Filings

Filed On Filing
10 Nov 2026 S-8
09 Nov 2026 10-Q
09 Nov 2026 8-K: Results of Operations and Financial Condition

Achieved substantial enrollment in FORTIFI-HN01 pivotal trial in 1L R/M HPV-negative HNSCC; topline results from interim analysis expected in mid-2027

21 Oct 2026 144
07 Oct 2026 SCHEDULE 13G/A
10 Sep 2026 Form 4: Cohlhepp Ryan, Director

Received 17,500 shares by exercise or conversion ($66.3K) · Sold 17,500 shares ($401K)

08 Sep 2026 144
08 Sep 2026 144
25 Aug 2026 8-K: Entry into a Material Definitive Agreement

This SUB-SUBLEASE AGREEMENT (this “Sub-Sublease”) is made as of August 21, 2026 (the “Effective Date”), by and between WAYFAIR LLC, a Delaware limited liability company having an office at 4 Copley Place, Boston, Massachusetts 02116 (“Su...

14 Aug 2026 Form 4: Larson Jennifer, Chief Financial Officer

Granted 285,000 Stock Option (Right to Buy)

14 Aug 2026 Form 3: Larson Jennifer, Chief Financial Officer

No securities owned

13 Aug 2026 SCHEDULE 13G/A
12 Aug 2026 Form 4: Hyep Ivan, Chief Financial Officer

Received 12,500 shares by exercise or conversion ($47.4K) · Sold 12,500 shares ($350K)

12 Aug 2026 Form 4: Mazumdar Claire, Director

Received 10,000 shares by exercise or conversion ($37.9K) · Sold 10,000 shares ($280K)

12 Aug 2026 Form 4: Cohlhepp Ryan, Director

Received 18,750 shares by exercise or conversion ($71.1K) · Sold 18,750 shares ($525K)

11 Aug 2026 S-8
11 Aug 2026 10-Q
11 Aug 2026 8-K: Results of Operations and Financial Condition

Bicara Therapeutics Reports Second Quarter 2026 Progress and Announces Strategic Leadership Transitions Marking Next Era of Execution and Growth

10 Aug 2026 144
10 Aug 2026 144

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support